These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 24746812)
1. Repair of radiographic hip joint in juvenile rheumatoid arthritis patients treated with etanercept plus methotrexate. Remy A; Combe B Joint Bone Spine; 2014 Oct; 81(5):447-9. PubMed ID: 24746812 [TBL] [Abstract][Full Text] [Related]
2. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139 [TBL] [Abstract][Full Text] [Related]
3. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. Bathon JM; Martin RW; Fleischmann RM; Tesser JR; Schiff MH; Keystone EC; Genovese MC; Wasko MC; Moreland LW; Weaver AL; Markenson J; Finck BK N Engl J Med; 2000 Nov; 343(22):1586-93. PubMed ID: 11096165 [TBL] [Abstract][Full Text] [Related]
4. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis. Culy CR; Keating GM Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111 [TBL] [Abstract][Full Text] [Related]
5. [Remarkable improvement of the hip joint lesion in a patient with rheumatoid arthritis by the treatment with anti-TNF-α agents]. Nagare Y; Kinoshita K; Nishisaka F; Saito M; Nonaka T; Funauchi M Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(5):272-6. PubMed ID: 21048388 [TBL] [Abstract][Full Text] [Related]
6. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Landewé R; van der Heijde D; Klareskog L; van Vollenhoven R; Fatenejad S Arthritis Rheum; 2006 Oct; 54(10):3119-25. PubMed ID: 17009230 [TBL] [Abstract][Full Text] [Related]
7. Repair of erosions occurs almost exclusively in damaged joints without swelling. Lukas C; van der Heijde D; Fatenajad S; Landewé R Ann Rheum Dis; 2010 May; 69(5):851-5. PubMed ID: 19846407 [TBL] [Abstract][Full Text] [Related]
8. Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis. Nerome Y; Imanaka H; Nonaka Y; Takei S Mod Rheumatol; 2007; 17(6):526-8. PubMed ID: 18084710 [TBL] [Abstract][Full Text] [Related]
9. Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis. Giannini EH; Ilowite NT; Lovell DJ; Wallace CA; Rabinovich CE; Reiff A; Higgins G; Gottlieb B; Singer NG; Chon Y; Lin SL; Baumgartner SW; Arthritis Rheum; 2009 Sep; 60(9):2794-804. PubMed ID: 19714630 [TBL] [Abstract][Full Text] [Related]
10. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. van der Heijde D; Klareskog L; Landewé R; Bruyn GA; Cantagrel A; Durez P; Herrero-Beaumont G; Molad Y; Codreanu C; Valentini G; Zahora R; Pedersen R; MacPeek D; Wajdula J; Fatenejad S Arthritis Rheum; 2007 Dec; 56(12):3928-39. PubMed ID: 18050208 [TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis. Eder L; Thavaneswaran A; Chandran V; Gladman DD Ann Rheum Dis; 2014 Jun; 73(6):1007-11. PubMed ID: 23619157 [TBL] [Abstract][Full Text] [Related]
12. Modern treatment strategies in rheumatoid arthritis. Hetland ML Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935 [TBL] [Abstract][Full Text] [Related]
13. Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing. Smolen JS; van der Heijde DM; Aletaha D; Xu S; Han J; Baker D; St Clair EW Ann Rheum Dis; 2009 Oct; 68(10):1535-40. PubMed ID: 18957487 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Klareskog L; van der Heijde D; de Jager JP; Gough A; Kalden J; Malaise M; Martín Mola E; Pavelka K; Sany J; Settas L; Wajdula J; Pedersen R; Fatenejad S; Sanda M; Lancet; 2004 Feb; 363(9410):675-81. PubMed ID: 15001324 [TBL] [Abstract][Full Text] [Related]
15. A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study. Lan JL; Chou SJ; Chen DY; Chen YH; Hsieh TY; Young M J Formos Med Assoc; 2004 Aug; 103(8):618-23. PubMed ID: 15340661 [TBL] [Abstract][Full Text] [Related]
16. Continuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week results from the JESMR study. Kameda H; Kanbe K; Sato E; Ueki Y; Saito K; Nagaoka S; Hidaka T; Atsumi T; Tsukano M; Kasama T; Shiozawa S; Tanaka Y; Yamanaka H; Takeuchi T J Rheumatol; 2011 Aug; 38(8):1585-92. PubMed ID: 21572151 [TBL] [Abstract][Full Text] [Related]
17. A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study. Schmeling H; Mathony K; John V; Keysser G; Burdach S; Horneff G Ann Rheum Dis; 2001 Apr; 60(4):410-2. PubMed ID: 11247875 [TBL] [Abstract][Full Text] [Related]
18. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. van der Heijde D; Klareskog L; Rodriguez-Valverde V; Codreanu C; Bolosiu H; Melo-Gomes J; Tornero-Molina J; Wajdula J; Pedersen R; Fatenejad S; Arthritis Rheum; 2006 Apr; 54(4):1063-74. PubMed ID: 16572441 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept. Fleischmann R; Iqbal I; Nandeshwar P; Quiceno A Drug Saf; 2002; 25(3):173-97. PubMed ID: 11945114 [TBL] [Abstract][Full Text] [Related]
20. Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. Davies R; Southwood TR; Kearsley-Fleet L; Lunt M; Hyrich KL; Arthritis Rheumatol; 2015 Sep; 67(9):2487-94. PubMed ID: 25989609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]